Cargando…

Long-term clinical course and outcomes of immunoglobulin G4-related lung disease

BACKGROUND: Immunoglobulin G4-related lung disease (IgG4-RLD) is the pulmonary manifestation of a systemic fibroinflammatory disease characterized by lymphoplasmacytic infiltration with an abundance of IgG4-positive plasma cells. Long-term clinical course and outcomes of IgG4-RLD remain unclear. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Jieun, Park, Shinhee, Chae, Eun Jin, Song, Joon Seon, Hwang, Hee Sang, Kim, Sun Jong, Song, Tae Jun, Kim, Myung-Whan, Song, Jin Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574178/
https://www.ncbi.nlm.nih.gov/pubmed/33076916
http://dx.doi.org/10.1186/s12931-020-01542-6
_version_ 1783597589457797120
author Kang, Jieun
Park, Shinhee
Chae, Eun Jin
Song, Joon Seon
Hwang, Hee Sang
Kim, Sun Jong
Song, Tae Jun
Kim, Myung-Whan
Song, Jin Woo
author_facet Kang, Jieun
Park, Shinhee
Chae, Eun Jin
Song, Joon Seon
Hwang, Hee Sang
Kim, Sun Jong
Song, Tae Jun
Kim, Myung-Whan
Song, Jin Woo
author_sort Kang, Jieun
collection PubMed
description BACKGROUND: Immunoglobulin G4-related lung disease (IgG4-RLD) is the pulmonary manifestation of a systemic fibroinflammatory disease characterized by lymphoplasmacytic infiltration with an abundance of IgG4-positive plasma cells. Long-term clinical course and outcomes of IgG4-RLD remain unclear. We aimed to identify clinical characteristics, treatment outcomes, and longitudinal pulmonary function changes in patients with IgG4-RLD according to the radiologic classification. METHODS: Chest computed tomography findings of 37 subjects were classified into five subtypes: solid nodular, bronchovascular, alveolar interstitial, round ground glass opacity, and alveolar consolidative. Radiologic treatment outcomes and longitudinal pulmonary function changes were compared among the different radiologic subtypes. RESULTS: The mean age of the subjects was 55.6 years, and 78.4% were male. Among the five radiologic subtypes, alveolar consolidative and solid nodular type were most common, accounting for approximately 29.7% each of the total cases. Prednisone with or without azathioprine was administered to 31 patients (median treatment duration 14 months). In the treated patients, serial images showed complete response or partial response in 77.4%. However, relapse was documented in 25.0% of those who showed complete or partial response. In patients whose longitudinal lung function data were available (n = 20), the lung function was found to be stable during follow-up. Alveolar consolidative type showed the highest complete response rate, whereas alveolar interstitial type showed the lowest response rate, either complete or partial. CONCLUSIONS: Most patients showed a favorable outcome with regards to radiologic improvement and maintenance of pulmonary function; however, the response differed according to the radiologic subtype.
format Online
Article
Text
id pubmed-7574178
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75741782020-10-20 Long-term clinical course and outcomes of immunoglobulin G4-related lung disease Kang, Jieun Park, Shinhee Chae, Eun Jin Song, Joon Seon Hwang, Hee Sang Kim, Sun Jong Song, Tae Jun Kim, Myung-Whan Song, Jin Woo Respir Res Research BACKGROUND: Immunoglobulin G4-related lung disease (IgG4-RLD) is the pulmonary manifestation of a systemic fibroinflammatory disease characterized by lymphoplasmacytic infiltration with an abundance of IgG4-positive plasma cells. Long-term clinical course and outcomes of IgG4-RLD remain unclear. We aimed to identify clinical characteristics, treatment outcomes, and longitudinal pulmonary function changes in patients with IgG4-RLD according to the radiologic classification. METHODS: Chest computed tomography findings of 37 subjects were classified into five subtypes: solid nodular, bronchovascular, alveolar interstitial, round ground glass opacity, and alveolar consolidative. Radiologic treatment outcomes and longitudinal pulmonary function changes were compared among the different radiologic subtypes. RESULTS: The mean age of the subjects was 55.6 years, and 78.4% were male. Among the five radiologic subtypes, alveolar consolidative and solid nodular type were most common, accounting for approximately 29.7% each of the total cases. Prednisone with or without azathioprine was administered to 31 patients (median treatment duration 14 months). In the treated patients, serial images showed complete response or partial response in 77.4%. However, relapse was documented in 25.0% of those who showed complete or partial response. In patients whose longitudinal lung function data were available (n = 20), the lung function was found to be stable during follow-up. Alveolar consolidative type showed the highest complete response rate, whereas alveolar interstitial type showed the lowest response rate, either complete or partial. CONCLUSIONS: Most patients showed a favorable outcome with regards to radiologic improvement and maintenance of pulmonary function; however, the response differed according to the radiologic subtype. BioMed Central 2020-10-19 2020 /pmc/articles/PMC7574178/ /pubmed/33076916 http://dx.doi.org/10.1186/s12931-020-01542-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kang, Jieun
Park, Shinhee
Chae, Eun Jin
Song, Joon Seon
Hwang, Hee Sang
Kim, Sun Jong
Song, Tae Jun
Kim, Myung-Whan
Song, Jin Woo
Long-term clinical course and outcomes of immunoglobulin G4-related lung disease
title Long-term clinical course and outcomes of immunoglobulin G4-related lung disease
title_full Long-term clinical course and outcomes of immunoglobulin G4-related lung disease
title_fullStr Long-term clinical course and outcomes of immunoglobulin G4-related lung disease
title_full_unstemmed Long-term clinical course and outcomes of immunoglobulin G4-related lung disease
title_short Long-term clinical course and outcomes of immunoglobulin G4-related lung disease
title_sort long-term clinical course and outcomes of immunoglobulin g4-related lung disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574178/
https://www.ncbi.nlm.nih.gov/pubmed/33076916
http://dx.doi.org/10.1186/s12931-020-01542-6
work_keys_str_mv AT kangjieun longtermclinicalcourseandoutcomesofimmunoglobuling4relatedlungdisease
AT parkshinhee longtermclinicalcourseandoutcomesofimmunoglobuling4relatedlungdisease
AT chaeeunjin longtermclinicalcourseandoutcomesofimmunoglobuling4relatedlungdisease
AT songjoonseon longtermclinicalcourseandoutcomesofimmunoglobuling4relatedlungdisease
AT hwangheesang longtermclinicalcourseandoutcomesofimmunoglobuling4relatedlungdisease
AT kimsunjong longtermclinicalcourseandoutcomesofimmunoglobuling4relatedlungdisease
AT songtaejun longtermclinicalcourseandoutcomesofimmunoglobuling4relatedlungdisease
AT kimmyungwhan longtermclinicalcourseandoutcomesofimmunoglobuling4relatedlungdisease
AT songjinwoo longtermclinicalcourseandoutcomesofimmunoglobuling4relatedlungdisease